Broadfin Capital, LLC 4
4 · BIODELIVERY SCIENCES INTERNATIONAL INC · Filed Aug 3, 2018
Insider Transaction Report
Form 4
KOTLER KEVIN
Director
Transactions
- Award
Stock Options (right to buy)
2018-08-01+48,123→ 48,123 totalExercise: $2.93Exp: 2028-08-01→ Common Stock (48,123 underlying) - Award
Restricted Stock Units
2018-08-01+96,247→ 96,247 totalExercise: $0.00Exp: 2022-08-01→ Common Stock (96,247 underlying)
Footnotes (2)
- [F1]The restricted stock units ("RSUs") were issued to the Reporting Person on August 1, 2018, as compensation for service on the Issuer's board of directors. The RSUs vest as follows: (i) 3,124 RSUs vest in the first open window following the filing of the Company's quarterly 10Q for June 30, 2018, (ii) 18,123 RSUs vest in the first open window following the Company's 2019 Annual Meeting of Stockholders, (iii) 30,000 RSUs vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (iv) 30,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (v) 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders.
- [F2]The stock options ("options") were issued to the Reporting Person on August 1, 2018, as compensation for service on the Issuer's board of directors. The options vest as follows: (i) 1,562 options vest in the first open window following the filing of the Company's quarterly 10Q for June 30, 2018, (ii) 9,061 options vest in the first open window following the Company's 2019 Annual Meeting of Stockholders, (iii) 15,000 options vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (iv) 15,000 options vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (v) 7,500 options vest in the first open window following the Company's 2022 Annual Meeting of Stockholders.